MEUD:LSE:LSE-Amundi Stoxx Europe 600 UCITS ETF C GBP (GBX)

ETF | Others |

Last Closing

USD 21740

Change

+155.00 (+0.72)%

Market Cap

N/A

Volume

4.84K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.45 (+0.99%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+82.00 (+0.43%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.39%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.21 (+1.13%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.64%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-1.38 (-1.14%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.60 (+2.35%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.36 (+1.18%)

USD 260.39B
0QZO:LSE 0QZO

+0.85 (+0.86%)

USD 258.54B

ETFs Containing MEUD:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.59% 87% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.59% 86% B+ 80% B-
Trailing 12 Months  
Capital Gain 10.65% 76% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.65% 74% C 68% D+
Trailing 5 Years  
Capital Gain 104.92% 70% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 104.92% 68% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 10.68% 63% D 67% D+
Dividend Return 10.68% 62% D 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.58% 66% D+ 80% B-
Risk Adjusted Return 100.97% 88% B+ 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike